A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia

Sponsor
Astex

Protocol Number
Astex SGI-110-06

To Learn More Call
201-510-0910